Modifying muscular dystrophy through transforming growth factor-β.

FEBS J 2013 Sep 24;280(17):4198-209. Epub 2013 Apr 24.

Committee on Cell Physiology, University of Chicago, IL 60637, USA.

Muscular dystrophy arises from ongoing muscle degeneration and insufficient regeneration. This imbalance leads to loss of muscle, with replacement by scar or fibrotic tissue, resulting in muscle weakness and, eventually, loss of muscle function. Human muscular dystrophy is characterized by a wide range of disease severity, even when the same genetic mutation is present. This variability implies that other factors, both genetic and environmental, modify the disease outcome. There has been an ongoing effort to define the genetic and molecular bases that influence muscular dystrophy onset and progression. Modifier genes for muscle disease have been identified through both candidate gene approaches and genome-wide surveys. Multiple lines of experimental evidence have now converged on the transforming growth factor-β (TGF-β) pathway as a modifier for muscular dystrophy. TGF-β signaling is upregulated in dystrophic muscle as a result of a destabilized plasma membrane and/or an altered extracellular matrix. Given the important biological role of the TGF-β pathway, and its role beyond muscle homeostasis, we review modifier genes that alter the TGF-β pathway and approaches to modulate TGF-β activity to ameliorate muscle disease.

Download full-text PDF

Source
http://dx.doi.org/10.1111/febs.12266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731412PMC
September 2013
3 Reads

Publication Analysis

Top Keywords

muscular dystrophy
20
tgf-β pathway
12
growth factor-β
8
muscle
8
transforming growth
8
muscle disease
8
modifier genes
8
loss muscle
8
dystrophy
5
tgf-β
5
define genetic
4
genetic molecular
4
ongoing effort
4
effort define
4
and/or altered
4
altered extracellular
4
bases influence
4
dystrophy onset
4
membrane and/or
4
influence muscular
4

Similar Publications